Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.

TitleNovel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.
Publication TypeJournal Article
Year of Publication2013
AuthorsTezgel ÖA, Gonzalez-Perez G, Telfer JC, Osborne BA, Minter LM, Tew GN
JournalMol Ther
Volume21
Issue1
Pagination201-9
Date Published2013 Jan
ISSN1525-0024
KeywordsCD4-Positive T-Lymphocytes, Cell Differentiation, Gene Knockdown Techniques, Humans, Jurkat Cells, Receptor, Notch1, RNA Interference, RNA, Small Interfering, Transduction, Genetic
Abstract

RNA interference technology has recently been highlighted as a powerful research method as well as a potential therapeutic treatment for several diseases. However, the delivery of small interfering RNA (siRNA) into T cell lines and primary blood cells is exceedingly challenging, as they are resistant to transfection by conventional reagents. As a result, there is an unmet need for nonviral, efficient, and easily prepared carriers for siRNA delivery into hard-to-transfect cell types. Here, we report a novel system based on protein transduction domain mimics (PTDMs), generated by ring opening metathesis polymerization, for intracellular delivery of siRNA molecules. PTDM-based siRNA delivery induced efficient NOTCH1 knockdown in Jurkat T cells and human peripheral blood mononuclear cells without any measured toxicity. Furthermore, delivering siRNA to NOTCH1 in human peripheral blood cells modulated cell proliferation and differentiation of T cells into T(H)1 cells.

DOI10.1038/mt.2012.209
Alternate JournalMol. Ther.
PubMed ID23070119